59 results
Page 2 of 3
8-K
EX-99.2
72icfbes96zdh
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
S-3
m1nc94x5u7e981xq1
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.6
mz8xf1gxw vh7
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
x3m e1nvg4
1 Jul 22
Shelf registration
4:13pm
424B3
efz6k0q8o scmkls
13 May 22
Prospectus supplement
8:18am
424B3
66aa0et1x 56ehhlly
31 Mar 22
Prospectus supplement
11:42am
POS AM
7t6ezgr
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
wc5fcev2paqh8eycjtr
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.1
qdd 7z2meg
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
ul2uwqr5zbt88b
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
w8tajqgmtz7d6
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
nyuq8
12 Nov 21
Prospectus supplement
8:41am
424B3
1shwtk2psxyk5294xho
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
dd4wisnt9n2g
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
go9xqc5g
5 Aug 21
Prospectus supplement
4:26pm